BIOCHEMISTRY-MOSCOW is a distinguished academic journal published by MAIK NAUKA/INTERPERIODICA/SPRINGER, focusing on pivotal research in the fields of biochemistry, biophysics, geriatrics, and broader medical sciences. Established in 1972, the journal has a rich history of disseminating critical findings and innovative studies, making significant contributions to the advancement of biochemical knowledge and applications. With its Q2 ranking in various categories including biochemistry and gerontology, the journal commands respect within the scientific community, offering a reputable platform for both established researchers and emerging scholars alike. Although traditionally not an open-access journal, it provides a wealth of information accessible through institutional subscriptions, ensuring the latest advancements reach a global audience. The journal aims to enhance understanding of biochemical processes and their implications for human health, and its commitment to high-quality peer-reviewed content has established it as a vital resource for those invested in the life sciences.

JOURNAL OF MOLECULAR RECOGNITION, published by Wiley, is an esteemed academic journal that has been at the forefront of molecular biology and structural biology research since its inception in 1988. With its ISSN 0952-3499 and E-ISSN 1099-1352, this journal serves as a vital platform for disseminating innovative studies and findings in the realms of biochemical interactions and molecular structure elucidation. Although currently positioned in Quartile 4 of both molecular and structural biology categories based on 2023 metrics, the journal is dedicated to advancing knowledge in quantitative and qualitative molecular recognition processes. Researchers, professionals, and students alike will find that this journal is instrumental in keeping abreast of cutting-edge developments in the field, even as it continues to build its impact and reputation within the dynamic research landscape. Located in the United Kingdom, it is committed to promoting a diverse range of studies that drive forward the understanding of molecular interaction phenomena, thus empowering its readership to contribute effectively to the field.

INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY, published by Pergamon-Elsevier Science Ltd, stands at the forefront of interdisciplinary research focusing on the biochemical and molecular processes in insects. This esteemed journal, with an ISSN of 0965-1748 and E-ISSN of 1879-0240, serves as a vital resource for scientists and researchers interested in the intricacies of insect physiology and genetics. With a significant presence in the academic community, it holds impressive rankings, including Q2 in Biochemistry and Q1 in Insect Science according to the latest quartiles, reflecting its critical role in advancing knowledge in these fields. The journal's convergence of content from 1992 to 2024 illustrates its commitment to fostering long-term scholarly discourse. Researchers will appreciate its impact within the Agricultural and Biological Sciences and its contributions to understanding the molecular biology of insects. Although not an open-access journal, it provides complementary insights into the biochemistry and genetics of insects, making it indispensable for anyone keen on pushing the boundaries of entomological science.

Molecular Biomedicine is a prestigious peer-reviewed journal published by SpringerNature, dedicated to advancing the fields of molecular biology and molecular medicine. With a commendable Q1 ranking in both categories for 2023, this journal stands out for its rigorous exploration of the biochemical processes underlying health and disease. Operating out of Germany, Molecular Biomedicine aims to provide comprehensive insights into cutting-edge research, facilitating interdisciplinary collaboration among researchers, healthcare professionals, and students alike. The journal's impact is reflected in its Scopus rankings, placing it in the upper echelons of the fields of biochemistry, genetics, and molecular biology. As an open access platform, it commits to disseminating knowledge widely, ensuring that pivotal discoveries are accessible to all. Researchers looking to publish in a dynamic environment that prioritizes innovation and application in the biomedical sciences will find Molecular Biomedicine an ideal outlet for their work.

BIOCHEMICAL SOCIETY TRANSACTIONS is a premier journal published by Portland Press Ltd, renowned for its rigorous dissemination of cutting-edge research in the field of biochemistry. Established in 1973 and currently spanning until 2024, this journal has solidified its standing with an impressive Q1 category ranking in Biochemistry, reflecting its commitment to high-quality scholarship and innovation. It plays a crucial role in bridging current biochemical research with its practical applications, making it an invaluable resource for researchers, professionals, and students alike. The journal enjoys a commendable position in the Scopus Ranks, sitting at Rank #105 out of 438 journals in its category, placing it in the 76th percentile among similar publications. While the journal maintains a subscription-only access policy, it promises to provide readers with comprehensive insights and discoveries that drive advancements in biochemistry and related fields. This journal is not just a repository of information; it is a vibrant community dedicated to the progress of biochemistry, making it essential reading for anyone involved in this dynamic discipline.

MOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.

IUBMB LIFE is a prestigious, peer-reviewed journal published by WILEY, dedicated to advancing the fields of biochemistry, molecular biology, and cell biology. With an impressive impact factor and consistently ranked in the Q1 and Q2 categories across multiple relevant disciplines—including Biochemistry, Genetics, and Clinical Biochemistry—this journal has established itself as a leading platform for disseminating innovative research and critical reviews that propel scientific discovery. The journal spans a converged publication period from 1999 to 2024, providing comprehensive insights into the dynamic landscape of biochemical research. Researchers, professionals, and students alike are invited to explore its Open Access options, ensuring that groundbreaking studies are accessible to a global audience. As it continues to shape the future of life sciences, IUBMB LIFE remains a vital resource for those seeking to enrich their understanding and contribute to these rapidly evolving fields.

Journal of Cellular Biochemistry is a premier academic journal dedicated to advancing the field of biochemistry and cellular biology. Published by Wiley, this influential journal has a significant impact factor that underscores its relevance and authority within the scientific community. With its ISSN 0730-2312 and E-ISSN 1097-4644, the journal has been on the frontier of research since its inception in 1982, and is expected to continue publishing cutting-edge studies through 2024. As evidenced by its ranking in the 2023 Scopus Quartiles, it holds a rank of Q2 in Biochemistry and Q3 in both Cell and Molecular Biology, placing it among the top tiers of scientific journals in these disciplines. The Journal of Cellular Biochemistry serves as a vital resource for researchers, professionals, and students alike, providing a platform for the dissemination of innovative ideas and findings that shape our understanding of cellular processes and biochemical pathways. Though it does not currently offer Open Access options, its robust peer-review process ensures that each publication meets the highest academic standards, thus solidifying its esteemed position in the landscape of biochemical research.

Welcome to BIOCHIMIE, a prestigious journal dedicated to advancing the field of biochemistry and related areas of medicine. Published by Elsevier France - Editions Scientifiques Medicales Elsevier, this journal has been a cornerstone of scientific communication since its inception in 1971 and will continue to contribute essential research until 2024. With an impressive impact factor and categorized in Q2 for Biochemistry and Q1 for Miscellaneous Medicine, BIOCHIMIE ranks among the top quartiles in its fields, underscoring its significance and influence in the scientific community. Targeting a wide audience of researchers, professionals, and students, the journal publishes high-quality articles that explore innovative research and developments in biochemistry, genetics, and molecular biology, reflected in its Scopus ranking of 136 out of 438 in the biochemistry category. Despite its traditional publication format, the journal remains committed to promoting impactful research that drives the future of biochemistry and molecular medicine, ensuring that readers have access to critical insights that foster advancements in health and science.

Journal of Biochemistry, published by Oxford University Press, is a prestigious academic journal that has been at the forefront of biochemical research since its inception in 1922. With an ISSN of 0021-924X and an E-ISSN of 1756-2651, this journal serves as a platform for disseminating high-quality research in the fields of biochemistry, molecular biology, and medicine, holding impressive rankings such as Q2 in Biochemistry and Medicine (miscellaneous) in 2023. As of 2024, the journal continues to explore significant topics in these areas, offering valuable insights for researchers, professionals, and students alike. The journal does not currently offer open access, but it remains a vital resource for anyone in the biochemical community seeking to stay updated on the latest discoveries and advancements. With its rich history and dedication to scientific excellence, the Journal of Biochemistry is an indispensable part of the scholarly landscape.